Mesothelioma Asbestos Cancer Information

  Malignant peritoneal pleural mesothelioma asbestos cancer and treatment information 

>> What is Mesothelioma?

>> What is the Mesothelium?

>> Mesothelioma Symptoms

>> Mesothelioma Diagnosed

>> Mesothelioma Treatment

>> Mesothelioma Studies

>> Risk Factors

>> Who is at Increased Risk

>> What is Asbestos?

>> Metastatic Cancer Info

>> Mesothelioma Updates

>> Health Professionals

>> Mesothelioma advanced stages(II,III,IV)

>> Mesothelioma cellular classification

>> Mesothelioma general information

>> Mesothelioma Lawyer & Attorney Rights

>> Mesothelioma localized stage I

>> Recurrent mesothelioma

>> Different stages of mesothelioma

>> who requires examination

>> Frequently asked questions

>> Government and asbestos protection

>> hazards of asbestos

>> Environmental exposure

>> Asbestos information-sources

>> Asbestos workers protection

>> Extent of risk

>> Smoking causes higher risk

>> Usage of asbestos

>> First Aid - Emergency Instructions

>> Links

 

 

 

 

 

Localized Malignant Mesothelioma (Stage I)

Standard treatment options:[1]

  1. Solitary mesotheliomas: Surgical resection en bloc including contiguous structures to ensure wide disease-free margins. Sessile polypoid lesions should be treated with surgical resection to ensure maximal potential for cure.[2]
  2. Intracavitary mesothelioma:
    1. Palliative surgery (pleurectomy and decortication) with or without postoperative radiation therapy.
    2. Extrapleural pneumonectomy.
    3. Palliative radiation therapy.

Treatment options under clinical evaluation:

  1. Intracavitary chemotherapy following resection.[3,4]
  2. Multimodality therapy.[4-6]
  3. Other clinical trials.

Information about ongoing clinical trials is available from the NCI Cancer.gov Web site.

References

  1. Antman KH, Li FP, Osteen R, et al.: Mesothelioma. Cancer: Principles and Practice of Oncology Updates 3(1): 1-16, 1989. 

  2. Martini N, McCormack PM, Bains MS, et al.: Pleural mesothelioma. Ann Thorac Surg 43 (1): 113-20, 1987.  [PUBMED Abstract]

  3. Markman M, Kelsen D: Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol 118 (7): 547-50, 1992.  [PUBMED Abstract]

  4. Rusch V, Saltz L, Venkatraman E, et al.: A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 12 (6): 1156-63, 1994.  [PUBMED Abstract]

  5. Sugarbaker DJ, Mentzer SJ, DeCamp M, et al.: Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma. Chest 103 (4 Suppl): 377S-381S, 1993.  [PUBMED Abstract]

  6. Vogelzang NJ: Malignant mesothelioma: diagnostic and management strategies for 1992. Semin Oncol 19 (4 Suppl 11): 64-71, 1992.  [PUBMED Abstract]
 

 

 

 

# # # 
Sources of National Cancer Institute Information

 

Mesothilioma, Mesotheliema,Mesothiliema,Mesotheleoma Mesosthelioma, Masesthilioma information:

 

 

 


free hit counter